new studies on glp 1 GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction Discovery of GLP-1–Based Drugs for

Beyond liver-specific outcomes, MASLD exerts a substantial extrahepatic disease burden

[1] These medications work by mimicking the action of naturally occurring GLP-1, a hormone released from the intestinal tract following food intake

If you're in your first 46 weeks of treatment, when side effects peak, avoiding alcohol entirely allows you to distinguish between medication effects and alcohol effects

Depo-Provera is a birth control shot that contains medroxyprogesterone acetate, a hormone that prevents pregnancy

G protein-coupled receptor kinase 2 (GRK2) as an integrative signalling node in the regulation of cardiovascular function and metabolic homeostasis

February 10, 2026: Clinical Study of Diabetic Retinopathy in Patients Taking Ozempic, Other Semaglutide Drugs Underway A large, 5-year clinical trial is being conducted to study diabetic retinopathy in patients taking semaglutide (like Ozempic) for diabetes